Umendra Exports Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Umendra Exports Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $2.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Umendra Exports Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $2.5M Trade | TransData Nexus

Umendra Exports Private Limited

Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $2.5M Total Trade · DGFT Verified

Umendra Exports Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.5M across 2 products in 2 therapeutic categories. Based on 150 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Zinc ($1.3M), Hydrocortisone ($1.1M), .

Umendra Exports Private Limited — Export Portfolio & Destination Treemap

Umendra Exports Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Umendra Exports Private Limited? — Company Overview & Market Position

Umendra Exports Private Limited, established on August 4, 1995, is a privately held company headquartered at 1102 Devika Tower, 6 Nehru Place, New Delhi, India. The company is classified as a private limited entity under the Corporate Identification Number (CIN) U74899DL1995PTC071444. As of the latest available data, Umendra Exports has an authorized share capital of ₹5 crore and a paid-up capital of ₹1 lakh. The company operates in the business services sector, focusing on the manufacturing and export of personal care products, over-the-counter (OTC) ointments and creams, and medical disposables. In the fiscal year ending March 2023, Umendra Exports reported a net profit margin of 2.77%, indicating a stable financial performance.

What Does Umendra Exports Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Zinc$1.3M 2Hydrocortisone$1.1M

Product Portfolio — Top 2 by Export Value

Umendra Exports Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Zinc	Vitamins & Supplements	$1.3M	101	1.6%	10
2	Hydrocortisone	Corticosteroids	$1.1M	49	1.8%	12

Umendra Exports Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $2.5M. The top category is Vitamins & Supplements (53.1% of portfolio), followed by Corticosteroids (46.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Umendra Exports Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Umendra Exports operates a manufacturing facility located in New Delhi, India. The plant specializes in the production of personal care products, OTC ointments and creams, and medical disposables. The company emphasizes the use of natural herbs and ingredients in its formulations, ensuring compliance with globally accepted norms. The manufacturing process adheres to stringent quality control measures to maintain product efficacy and safety.

3Key Leadership

The leadership team at Umendra Exports Private Limited comprises:

Sumit Devendra Rajani: Director since August 4, 1995.

Sandeep Devendra Rajani: Director since August 4, 1995.

Both directors have been instrumental in steering the company's strategic direction and operational growth.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Umendra Exports Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Umendra Exports Private Limited's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's focus appears to be on manufacturing and exporting personal care products, OTC ointments and creams, and medical disposables. However, specific regulatory approvals or market access statuses in these regions are not provided. For comprehensive information on regulatory filings and approvals, it is recommended to consult the respective regulatory bodies or the company's official communications.

2Emerging Markets

Umendra Exports Private Limited has expanded its reach to over 40 countries, indicating a significant presence in emerging markets. The company's established brands, Smarth and Dr. Smarth, have sold over 12,000 metric tonnes globally, reflecting strong market penetration. While specific details regarding WHO prequalification are not available, the company's extensive distribution network suggests a strategic approach to accessing diverse markets.

3Geographic Strategy

Umendra Exports Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Umendra Exports Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not available in the provided sources. For detailed insights into the company's FDA status, it is advisable to consult the FDA's official database or the company's regulatory filings.

2WHO & EU GMP

The available information does not specify whether Umendra Exports Private Limited holds WHO prequalification or EU Good Manufacturing Practice (GMP) certificates. Given the company's focus on personal care products and OTC items, obtaining such certifications would be beneficial for accessing international markets. For precise details, it is recommended to contact the company directly or consult the World Health Organization and European Medicines Agency databases.

3CDSCO & Indian Regulatory

Umendra Exports Private Limited operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company's manufacturing facility is located in New Delhi, which falls under the jurisdiction of the Delhi State Drug Controller. Specific details regarding manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not provided in the available sources. For comprehensive regulatory information, it is advisable to consult the CDSCO or the company's official communications.

Umendra Exports Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Umendra Exports Private Limited operates in the personal care products and OTC ointments and creams sector, facing competition from both domestic and international manufacturers. While specific competitors are not identified in the available sources, the company's established brands, Smarth and Dr. Smarth, have sold over 12,000 metric tonnes globally, indicating a strong market presence. The emphasis on natural ingredients and compliance with global standards positions Umendra Exports favorably in the competitive landscape.

2Key Differentiators

Umendra Exports Private Limited differentiates itself through its commitment to using natural herbs and ingredients in product formulations, ensuring compliance with globally accepted norms. The company's established brands, Smarth and Dr. Smarth, have a significant global footprint, with over 12,000 metric tonnes sold worldwide. Additionally, the focus on private label solutions allows clients to market products under their own brand, tailored to specific consumer preferences.

3Strategic Position

Umendra Exports Private Limited's strategic direction centers on manufacturing and exporting personal care products, OTC ointments and creams, and medical disposables. The company's emphasis on private label solutions enables clients to offer exclusive products under their own brand names, fostering brand differentiation and customer loyalty. Looking ahead, the company is well-positioned to expand its market presence by leveraging its established brands and commitment to quality.

Buyer Due Diligence Brief — Evaluating Umendra Exports Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Umendra Exports Private Limited has demonstrated a consistent track record in manufacturing and exporting personal care products and OTC ointments and creams. The company's established brands, Smarth and Dr. Smarth, have sold over 12,000 metric tonnes globally, reflecting a reliable supply chain and product acceptance in diverse markets. The focus on natural ingredients and adherence to global standards further underscores the company's commitment to quality and reliability.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's facility registration with the U.S. Food and Drug Administration. Verification can be done through the FDA's official database.

WHO-GMP Certification: Check for certification from the World Health Organization's Good Manufacturing Practices. This can be verified through the WHO's official website.

Frequently Asked Questions — Umendra Exports Private Limited

How many pharmaceutical products does Umendra Exports Private Limited export from India?

Umendra Exports Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Zinc ($1.3M), Hydrocortisone ($1.1M). Total export value is $2.5M.

What is Umendra Exports Private Limited's total pharmaceutical export value?

Umendra Exports Private Limited's total pharmaceutical export value is $2.5M, based on 150 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Umendra Exports Private Limited cover?

Umendra Exports Private Limited exports across 2 therapeutic categories. The largest are Vitamins & Supplements (53.1%, 1 products), Corticosteroids (46.9%, 1 products).

Get Full Umendra Exports Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.